Here's Why You Should Retain Ventas Stock in Your Portfolio Now

Here’s Why You Should Retain Ventas Stock in Your Portfolio Now

Ventas’ VTR senior housing operating portfolio (SHOP) is likely to benefit from the aging population and the rising healthcare expenditures by senior citizens. Its outpatient medical and research (OM&R) portfolio is expected to gain from the favorable demographics and outpatient visit trends. Efforts to enhance its liquidity position are likely to support its growth endeavors.

However, competition from national and local healthcare operators and dependence on few tenants add to this healthcare real estate investment trust (REIT) company’s concerns.

The senior citizens’ population is expected to rise in the years ahead. As a result, the national healthcare expenditure by senior citizens, who constitute a major customer base of healthcare services and incur higher healthcare expenditures than the average population, will likely increase in the upcoming period. Hence, Ventas’ SHOP portfolio is well-poised to capitalize on this positive trend.

Ventas is focused on its “Right Market, Right Asset, Right Operator” strategy, enhancing its portfolio quality and operator diversification and increasing its SHOP scale. The company expects favorable supply-demand fundamentals, its well-invested properties and operators supported by its Ventas OI platform to drive growth. In 2024, Ventas expects its SHOP segment’s same-store cash NOI to grow between 14-16%, up from the previous guided range of 13-16%.

Ventas is carrying out accretive investments to enhance its research portfolio that is essential for the delivery of crucial healthcare services and research related to life-saving vaccines and therapeutics. Its OM&R assets are aligned with institutional demand with several top-tier research universities and credit tenancy.

With top-rated tenants and long-lease terms, its high-quality portfolio assures steady growth in cash flows. In the OM&R portfolio, Ventas generated 2.1% same-store cash NOI growth in the third quarter of 2024. The company expects the OM&R portfolio’s same-store cash NOI to grow in the range of 2.75-3.25% in 2024.

Ventas has been making efforts to enhance its liquidity position and financial strength. As of Sept. 30, 2024, the company had approximately $4 billion of liquidity. Its net debt to further adjusted EBITDA of 6.3X improved sequentially from 6.4X. It has also substantially cleared 2024 debt maturities and proactively refinanced a portion of its 2025 debt maturities. Its access to diverse capital sources through capital recycling, third party (VIM), on-balance sheet financing and internal cash flow provides ample financial flexibility and is likely to support its growth endeavors.

More From Author

5 Mining Stocks to Add Shine to Your Portfolio Before the Year Ends

5 Mining Stocks to Add Shine to Your Portfolio Before the Year Ends

Here's Why You Should Retain Kennametal Stock in Your Portfolio

Here’s Why You Should Retain Kennametal Stock in Your Portfolio

Leave a Reply

Your email address will not be published. Required fields are marked *